Annual Total Liabilities
$10.16 M
+$3.61 M+55.04%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual total liabilities is $10.16 million, with the most recent change of +$3.61 million (+55.04%) on June 1, 2024.
- During the last 3 years, NEUP annual total liabilities has risen by +$5.15 million (+102.84%).
Performance
NEUP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
$4.42 M
-$1.43 M-24.40%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly total liabilities is $4.42 million, with the most recent change of -$1.43 million (-24.40%) on December 1, 2024.
- Over the past year, NEUP quarterly total liabilities has stayed the same.
Performance
NEUP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NEUP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.0% | 0.0% |
| 3 y3 years | +102.8% | 0.0% |
| 5 y5 years | -59.7% | 0.0% |
NEUP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -50.7% | -56.5% | at low |
| 5 y | 5-year | -59.7% | -50.7% | -80.8% | at low |
| alltime | all time | -71.3% | -98.6% | -87.5% | -96.5% |
Neuphoria Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $4.42 M(-24.4%) |
| Sep 2024 | - | $5.85 M(-42.4%) |
| Jun 2024 | - | $10.16 M(+51.8%) |
| Jun 2024 | $10.16 M(+55.0%) | - |
| Dec 2023 | - | $6.69 M(+2.1%) |
| Jun 2023 | $6.55 M(+13.4%) | $6.55 M(+12.2%) |
| Dec 2022 | - | $5.84 M(+1.1%) |
| Jun 2022 | $5.78 M(+15.3%) | $5.78 M(+5.4%) |
| Dec 2021 | - | $5.48 M(+9.4%) |
| Jun 2021 | $5.01 M(-66.5%) | $5.01 M(-53.6%) |
| Dec 2020 | - | $10.80 M(-27.8%) |
| Jun 2020 | $14.97 M(-40.6%) | $14.97 M(-35.0%) |
| Dec 2019 | - | $23.02 M(-8.6%) |
| Jun 2019 | $25.18 M(-28.7%) | $25.18 M(-22.3%) |
| Dec 2018 | - | $32.42 M(-8.3%) |
| Jun 2018 | $35.34 M(+5.4%) | $35.34 M(+3.9%) |
| Dec 2017 | - | $34.01 M(+1.5%) |
| Jun 2017 | $33.52 M(-1.5%) | $33.52 M(+6.9%) |
| Dec 2016 | - | $31.35 M(-7.9%) |
| Jun 2016 | $34.04 M(+19.4%) | $34.04 M(+8.3%) |
| Dec 2015 | - | $31.44 M(+10.3%) |
| Jun 2015 | $28.51 M(+49.6%) | $28.51 M(+10.0%) |
| Dec 2014 | - | $25.92 M(+36.0%) |
| Jun 2014 | $19.06 M(+71.1%) | $19.06 M(+28.3%) |
| Dec 2013 | - | $14.85 M(+33.3%) |
| Jun 2013 | $11.14 M | $11.14 M(+15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $9.63 M(+80.8%) |
| Jun 2012 | $5.32 M(-11.2%) | $5.32 M(+55.4%) |
| Dec 2011 | - | $3.43 M(-42.9%) |
| Jun 2011 | $6.00 M(+16.6%) | $6.00 M(+4.0%) |
| Dec 2010 | - | $5.77 M(+12.2%) |
| Jun 2010 | $5.14 M(+5.6%) | $5.14 M(+7.9%) |
| Dec 2009 | - | $4.76 M(-2.1%) |
| Jun 2009 | $4.87 M(-25.0%) | $4.87 M(+3.3%) |
| Dec 2008 | - | $4.71 M(-27.4%) |
| Jun 2008 | $6.49 M(-5.8%) | $6.49 M(+9.4%) |
| Dec 2007 | - | $5.93 M(-13.9%) |
| Jun 2007 | $6.89 M(+5.9%) | $6.89 M(+3.9%) |
| Dec 2006 | - | $6.63 M(+1.9%) |
| Jun 2006 | $6.51 M(+33.9%) | $6.51 M(+4.5%) |
| Dec 2005 | - | $6.22 M(+28.1%) |
| Jun 2005 | $4.86 M(+15.2%) | $4.86 M(-2.5%) |
| Dec 2004 | - | $4.98 M(+18.2%) |
| Jun 2004 | $4.22 M(+6.9%) | $4.22 M(-12.3%) |
| Dec 2003 | - | $4.81 M(+21.9%) |
| Jun 2003 | $3.95 M(+19.8%) | $3.95 M(+17.1%) |
| Dec 2002 | - | $3.37 M(+2.3%) |
| Jun 2002 | $3.29 M(+904.7%) | $3.29 M(+835.1%) |
| Dec 2001 | - | $352.20 K(+7.4%) |
| Jun 2001 | $327.80 K(+123.3%) | $327.80 K(+113.3%) |
| Dec 2000 | - | $153.70 K |
| Jun 2000 | $146.80 K(-71.0%) | - |
| Jun 1999 | $506.00 K | - |
FAQ
- What is Neuphoria Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual total liabilities year-on-year change?
- What is Neuphoria Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly total liabilities year-on-year change?
What is Neuphoria Therapeutics annual total liabilities?
The current annual total liabilities of NEUP is $10.16 M
What is the all time high annual total liabilities for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual total liabilities is $35.34 M
What is Neuphoria Therapeutics annual total liabilities year-on-year change?
Over the past year, NEUP annual total liabilities has changed by +$3.61 M (+55.04%)
What is Neuphoria Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NEUP is $4.42 M
What is the all time high quarterly total liabilities for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly total liabilities is $35.34 M
What is Neuphoria Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NEUP quarterly total liabilities has changed by $0.00 (0.00%)